Next Generation Sequencing (NGS) Market Statistics

1
Next Generation Sequencing (NGS) Market Trends,
Size, Share, Demands, Overview, Growth, Revenue
and Forecast to 2030
sales_at_delvens.com www.delvens.com
2
Sternal Closure Systems Market Trends Forecast
Till 2030
Next Generation Sequencing (NGS) Market, by
Product (Consumables, Platforms, Services and
Nerve Blockers), Application (Diagnostics,
Biomarkers and Cancer, Reproductive Health,
Personalized Medicine, Agriculture and Animal
Research, and Other Applications), Technology
(Sequencing by Synthesis, Ion Semiconductor
Sequencing, Sequencing by Ligation,
Pyrosequencing, Single Molecule Real Time
Sequencing, and Other Technologies), and End User
(Academic and Research Centers, Pharmaceutical
and Biotechnology Companies, Hospitals and
Clinics, and Other End Users) and region (North
America, Europe, Asia-Pacific, Middle East and
Africa and South America).
Request For Free Sample Report
https//www.delvens.com/report/next-generation-seq
uencing-ngs-market
sales_at_delvens.com
www.delvens.com
3
Market Overview
Next-generation sequencing (NGS) is a massively
parallel sequencing method that offers
scalability, high throughput, and high speed for
genome-wide sequencing of nucleotides. Because it
involves the preparation of material for the
subsequent sequencing reaction, DNA presequencing
is one of the most important processes in a
common sequencing protocol. Globally, NGS is
increasingly integrated into clinical laboratory
analysis, testing and disease diagnosis in the
healthcare industry. In pharmacogenomics,
next-generation sequencing (NGS) is often used to
accelerate the drug discovery process. Purchase
this Report https//www.delvens.com/checkout/next
-generation-sequencing-ngs-market
sales_at_delvens.com
www.delvens.com
4
Market Overview
The growth of the global next-generation
sequencing market is primarily driven by the
growth of genome mapping programs proliferation
of next-generation sequencing applications
rising health care costs and technological
advances in sequencing platforms. For example, in
2019, Thermo Fisher Scientific, a world leader in
scientific services, launched a new generation
platform, the Ion Torrent Genexus System, which
provides sample for one-day reporting. Additional
ly, Agilent Technologies, Inc., an American
analytical development and manufacturing company,
brought in 2019, we launched the Magnis NGS Prep
System, a next-generation sequencing library
preparation system designed to perform complex
sequencing analyzes at the push of a button.
Fetal genetic makeup and configuration can be
detected with NGS-oriented tests such as
non-invasive prenatal testing (NIPT) and
pre-implantation genetic testing (PGT).
RD-related NGS has risen to new heights thanks
to investments in NGS technologies worldwide.
Growing demand for genome mapping software and
increasing use of NGS is fueling market growth
sales_at_delvens.com
www.delvens.com
5
Key Findings
The Next Generation Sequencing (NGS) Market is
segmented into various segments such product,
application, technology, end-user and
region The application segment is further
fragmented into diagnostics, biomarkers cancer,
reproductive health, personalized medicine,
agriculture animal research, and other
applications.  The product type segment is
further bifurcated into Consumables, Platforms,
Services and Nerve Blockers. The consumables
segment is the largest market during the forecast
period owing to development of technology in
molecular genetics and surge in demand for novel
pre-sequencing products and kits that execute DNA
fragmentation, target enrichment, size selection,
and others.
sales_at_delvens.com
www.delvens.com
6
Key Findings
The end user segment is further bifurcated into
Academic and Research Centers, Pharmaceutical and
Biotechnology Companies, Hospitals and Clinics,
and Other End Users. The market is also divided
into various regions such as North America,
Europe, Asia-Pacific, South America, and Middle
East and Africa. North America is estimated to
account for the largest market share during the
forecast period. Inquire Before Buying
https//www.delvens.com/Inquire-before-buying/next
-generation-sequencing-ngs-market
sales_at_delvens.com
www.delvens.com
7
Competitive Landscape

• 10X Genomics
• Agilent Technologies
• BGI Group
• Bio-Rad Laboratories Inc.
• Brooks Automation Inc.
• CD Genomics
• DNASTAR Inc.
• Eurofins Scientific
• F. Hoffmann-La Roche Ltd.
• Illumina Inc.
• Macrogen Inc.
• New England Biolabs

• Novogene Corporation Inc.
• Oxford Nanopore Technologies
• Pacific Biosciences of California Inc.
• PerkinElmer Inc.
• Precigen Inc., (Intrexon Bioinformatics Germany
  GmbH)
• Promega Corporation
• Psomagen
• Qiagen
• Takara Bio
• Tecan Trading Group
• Thermo Fisher Scientific Inc.

sales_at_delvens.com
www.delvens.com
8
Recent Developments

• In January, 2023, QIAGEN announced a strategic
  partnership with California-based population
  genomics leader Helix to advance next-generation
  sequencing companion diagnostics in hereditary
  diseases. 
• In March, 2023, The company SOPHiA GENETICS
  announced a new partnership with Qiagen that will
  pair QIAseq reagent technology with the DDM
  platform to enhance tumor analysis through
  next-generation sequencing (NGS).

sales_at_delvens.com
www.delvens.com
9
Contact Information
About Us Delvens is a strategic advisory and
consulting company headquartered in New Delhi,
India. The company holds expertise in providing
syndicated research reports, customized research
reports and consulting services. Delvens
qualitative and quantitative data is highly
utilized by each level from niche to major
markets, serving more than 1K prominent companies
by assuring to provide the information on
country, regional and global business
environment. We have a database for more than 45
industries in more than 115 major countries
globally. Contact us 44-20-3290-6466 1
214-377-1144 sales_at_delvens.com
sales_at_delvens.com
www.delvens.com